// App-Quantinova.ai

: Evaluation of PUMA and NOXA expression as predictive biomarkers in prostate cancer.

Researchers

Presenter

  • Sylvie Clairefond

Principal Investigators

  • Benjamin Pant

  • Veronique Ouellet

  • Veronique Barres

  • Anne-Marie Mes-Masson

  • Fred Saad

Medical Centers

  • CRCHUM, Institut du Cancer de Montreal, Montreal, QC, Canada

  • Research Center of the Universite de Montreal Hospital Center (CRCHUM) - Institut du Cancer de Montreal, Montreal, QC, Canada

  • Centre Hospitalier de LUniversite de Montreal (CHUM), Montreal, QC, Canada

  • Centre Hospitalier de LUniversite de Montreal (CHUM), Montreal, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • BCL2 Binding Component 3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved